Advertisement
Screener

Glucotrack, Inc. (GCTK) Overview

Glucotrack, Inc. (GCTK) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.76; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 2.65; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 4.64; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 9.62; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.11$0.27$0.65$1.55$3.74$8.992025-09-292026-09-29$0.11$1.42$17.95$227.48$2,883.08$36,540.002021-09-292026-09-29$0.11$2.34$49.02$1,026.77$21,506.00$450,450.002016-09-292026-09-29$0.11$2.64$62.26$1,469.79$34,695.21$819,000.002013-04-252026-09-29$0.11$2.64$62.26$1,469.79$34,695.21$819,000.002013-04-252026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$1.74
Previous close
$1.80
Change
-$0.06
Change (%)
-3.33%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

GCTK
-96.96%
S&P 500
(m)

1 year

GCTK
-98.16%
S&P 500
(m)

3 years

GCTK
-99.99%
S&P 500
(m)

5 years

GCTK
-100.00%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.76

0.6810.5920.5030.4140.3231 Mar 2025: estimate (m); actual 40.1431 Mar 2025(m)30 Jun 2025: estimate (m); actual 9.6230 Jun 2025(m)30 Sept 2025: estimate (m); actual 4.6430 Sept 2025(m)31 Mar 2026: estimate (m); actual 2.6531 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.7630 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.76(m)(m)
1 Jan 202631 Mar 2026(m)2.65(m)(m)
1 Jul 202530 Sept 2025(m)4.64(m)(m)
1 Apr 202530 Jun 2025(m)9.62(m)(m)
1 Jan 202531 Mar 2025(m)40.14(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 31.22

0.181026.682053.183079.684106.1831 Dec 2021: estimate (m); actual 0.2631 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.2931 Dec 2022(m)31 Dec 2023: estimate (m); actual 34.1831 Dec 2023(m)31 Dec 2024: estimate (m); actual 4106.0031 Dec 2024(m)31 Dec 2025: estimate (m); actual 31.2231 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)31.22(m)(m)
1 Jan 202431 Dec 2024(m)4106.00(m)(m)
1 Jan 202331 Dec 2023(m)34.18(m)(m)
1 Jan 202231 Dec 2022(m)0.29(m)(m)
1 Jan 202131 Dec 2021(m)0.26(m)(m)

Revenue vs. Earnings

USD

30 Jun 2020 ■ Revenue 0.10K ■ Earnings -574.00K — Profit margin -591752.58%

-1129.65K-591753.6%-671.97K-394773.2%-214.29K-197792.7%243.39K-812.3%30 Jun 2019: revenue 110.52K; earnings -898.86K; profit margin -813.31%30 Jun 201930 Sept 2019: revenue 4.17K; earnings -996.78K; profit margin -23874.90%30 Sept 201931 Mar 2020: revenue 2.17K; earnings -734.00K; profit margin -33762.65%31 Mar 202030 Jun 2020: revenue 0.10K; earnings -574.00K; profit margin -591752.58%30 Jun 2020

31 Dec 2019 ■ Revenue 0.21M ■ Earnings 3.52M — Profit margin 1690.38%

-8.76M-15443.0%-1.72M-9710.9%5.33M-3978.8%12.37M1753.2%31 Dec 2016: revenue 0.61M; earnings -5.41M; profit margin -884.39%31 Dec 201631 Dec 2017: revenue 0.59M; earnings 10.33M; profit margin 1752.24%31 Dec 201731 Dec 2018: revenue 0.04M; earnings -6.72M; profit margin -15442.01%31 Dec 201831 Dec 2019: revenue 0.21M; earnings 3.52M; profit margin 1690.38%31 Dec 2019

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$1.74(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$1.74High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning GCTK

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-13; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
4.20M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-21.62%*
Total return · month
-58.87%*
Total return · quarter
-62.06%*
Total return · half year
-88.12%*
Total return · year to date
-96.96%*
Total return · 1 year
-98.16%*
Total return · 3 years
-99.99%*
Total return · 5 years
-100.00%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Glucotrack, Inc. Overview

View more →

(m)

(m)

SEC CIK
1506983
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
301 RT 17 NORTH, SUITE 800, RUTHERFORD, New Jersey, 07070, United States
Fiscal year end
1231
Phone
972 (8) 675-7878

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACCURAY INC (ARAY)United States$0.027B-0.63
PAVmed Inc. (PAVM)United States$0.031B-3.00
InspireMD, Inc. (NSPR)$0.033B
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47